Mary Glenn Vreeland has extensive work experience in the clinical research industry. Mary Glenn is currently serving as the Senior Director of Evidence at Worldwide Clinical Trials since December 2020. Prior to that, they held the position of Senior Director of Operations, Real World Solutions at PRA Health Sciences from March 2020 to December 2020. In 2019, they worked as the Senior Director of Project Management at Sarah Cannon, from January to September. From 2018 to 2019, they held the position of Senior Director of Evidence Project Management at Worldwide Clinical Trials. Before that, they worked at Continuum Clinical as a Senior Director from 2014 to 2018. Mary Glenn also worked at ICON Clinical Research as a Principal Project Manager and Associate Director from 2004 to 2011. Their earlier experience includes roles at Ovation Research Group and The Sachs Group.
Mary Glenn Vreeland holds a Master of Health Administration degree from Washington University School of Medicine in St. Louis.
Current role
Sr. Director, Biologics Value Chain Lead, Immuno-oncology Franchise at Bristol-Myers Squibb
Accounts Payable Manager at Seismic
Risk Manager at BNP Paribas
Supply Chain Director Team Leader at Pfizer
Technology Director, Leadership Advisory at Spencer Stuart
Access the worlds's biggest network of public org charts
Learn more